Physician profile
David C Hall
NPI 1689709214
$1,452.41
in general payments reported to CMS, 2019-2025
9 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $211 · 2021: $155 · 2022: $276 · 2023: $143 · 2024: $297 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557 · Gift: $90.11 · Entertainment: $23.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.80 |
| Gift | $90.11 |
| Entertainment | $23.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $596.92 | 2020-2025 | |
| Southern Implants North America INC | $189.85 | 2019-2023 | |
| Keystone Dental INC. | $169.30 | 2020-2024 | |
| Axogen | $165.71 | 2022 | |
| Nobel Biocare USA | $134.87 | 2019-2020 | |
| Dentsply Sirona INC | $83.59 | 2024 | Astra Tech Implant System |
| Geistlich Pharma, North America, INC. | $59.78 | 2021-2022 | |
| Biohorizons Implant Systems INC. | $31.33 | 2019-2025 | Biohorizons Dental Implants |
| E.R. Squibb & Sons, L.L.C. | $21.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.